ESR1 Mutated Metastatic Breast Cancer Diagnostics Market

ESR1 Mutated Metastatic Breast Cancer Diagnostics Market

ESR1 Mutated Metastatic Breast Cancer Diagnostics Market: Global Industry Analysis 2019-2023 and Opportunity Assessment 2024-2034

A recent market study published by FMI on ESR1 Mutated Metastatic Breast Cancer Diagnostics offers a global industry analysis for 2019-2023 and opportunity assessment for 2024-2034. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

By Test Type:
  • NGS Based
  • PCR Based
By Sample Type:
  • Tissue
  • Plasma
By End-user:
  • Hospital Associated Labs
  • Independent Diagnostic Laboratories
  • Diagnostic Imaging Centers
  • Cancer Research Institutes
By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA
Report Chapters

Executive Summary

The executive summary of the ESR1 Mutated Metastatic Breast Cancer Diagnostics Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Vehicle Radar Test System.

Chapter 01 - Market Overview

Readers can find the detailed segmentation and definition of the ESR1 Mutated Metastatic Breast Cancer Diagnostics Market in this chapter, which will help to understand basic information about Vehicle Radar Test System. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of ESR1 Mutated Metastatic Breast Cancer Diagnostics Market report.

Chapter 02 - Market Background

This chapter includes detailed analysis of the By Test Type processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.

Chapter 03 - Global ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Demand Analysis 2019-2023 and Forecast, 2024-2034

The chapter include historical market value (US$ 61.0 million) analysis (2019-2023) and current and future market value (US$ 63.4 million) and volume (3.7%) projections (2024-2034). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.

Chapter 04 - Global ESR1 Mutated Metastatic Breast Cancer Diagnostics Market - Pricing Analysis

Based on By Test Type, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.

Chapter 05 - Global ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Analysis 2019-2023 and Forecast 2024-2034, By Test Type

Based on By Test Type, ESR1 Mutated Metastatic Breast Cancer Diagnostics Market is segmented into NGS Based, PCR Based. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Test Type.

Chapter 06 - Global ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Analysis 2019-2023 and Forecast 2024-2034, By Sample Type

Based on By Sample Type, ESR1 Mutated Metastatic Breast Cancer Diagnostics Market is segmented into Tissue, Plasma. This section also offers market attractiveness analysis based on By Sample Type. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Sample Type.

Chapter 07 - Global ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Analysis 2019-2023 and Forecast 2024-2034, By End-user

Based on By End-user, ESR1 Mutated Metastatic Breast Cancer Diagnostics Market is segmented into Hospital Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By End-user.

Chapter 08 - ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Analysis 2019-2023 and Forecast 2024-2034, By Region

Based on By Region, ESR1 Mutated Metastatic Breast Cancer Diagnostics Market is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania and MEA. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.

Chapter 09 - North America ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Analysis 2019-2023 and Forecast 2024-2034

This chapter includes a detailed analysis of the growth of the Vehicle Radar Test System in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.

Chapter 10 - Latin America ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Analysis 2019-2023 and Forecast 2024-2034

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the ESR1 Mutated Metastatic Breast Cancer Diagnostics Market in the Latin America region.

Chapter 11 - Europe ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Analysis 2019-2023 and Forecast 2024-2034

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the ESR1 Mutated Metastatic Breast Cancer Diagnostics Market in the regional market.

Chapter 12 - East Asia ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Analysis 2019-2023 and Forecast 2024-2034

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the ESR1 Mutated Metastatic Breast Cancer Diagnostics Market in the regional market.

Chapter 13 - South Asia ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Analysis 2019-2023 and Forecast 2024-2034

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the ESR1 Mutated Metastatic Breast Cancer Diagnostics Market in the regional market.

Chapter 14 - Middle East and Africa ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Analysis 2019-2023 and Forecast 2024-2034

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the ESR1 Mutated Metastatic Breast Cancer Diagnostics Market in the regional market.

Chapter 15 - Key Countries ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Analysis 2019-2023 and Forecast 2024-2034

This chapter offers insights into how the ESR1 Mutated Metastatic Breast Cancer Diagnostics Market is expected to grow in major countries globally.

Chapter 16 - Market Structure Analysis- Global Assessment

This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.

Chapter 17 - Competition Deep Dive (Tentative List)

This chapter includes company overview, By Test Type portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are APIS Assay Technologies, Illumina, Inc., GENCURIX, RainSure Scientific, NeoGenomics Laboratories, Sysmex Corporation, ASURAGEN, INC., Guardant Health.

Chapter 18 - Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Vehicle Radar Test System report.

Chapter 19 - Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on ESR1 Mutated Metastatic Breast Cancer Diagnostics Market.


1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Development/Innovation Trends
4. Value Added Insights
4.1. Product Adoption/ Usage Analysis
4.2. Regulatory Scenario, By Country
4.2.1. Regulatory Frameworks in United States
4.2.2. Regulatory Frameworks in Europe
4.2.3. Regulatory Frameworks in Australia
4.2.4. Regulatory Frameworks in China
4.2.5. Regulatory Frameworks in Japan
4.2.6. Regulatory Frameworks in India
4.3. PESTEL Analysis
4.4. PORTER Analysis
4.5. Value Chain Analysis
4.6. Unmet Needs Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Expenditure Outlook
5.1.2. Global Life Expectancy Outlook
5.1.3. R&D Funding By Region
5.1.4. R&D Funding By Country
5.1.5. Global Breast Cancer Diagnostics Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Technological Advancements
5.2.2. Regulatory Landscape
5.2.3. Research and Development Initiatives
5.2.4. Market Consolidation and Partnerships
5.2.5. Patient Awareness and Advocacy
5.2.6. Healthcare Infrastructure Development
5.2.7. Reimbursement Policies
5.2.8. Emerging Market Trends
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Demand (in Value or Size in US$ million) Analysis 2019 to 2022 and Forecast, 2024 to 2034
6.1. Historical Market Value (US$ million) Analysis, 2019 to 2022
6.2. Current and Future Market Value (US$ million) Projections, 2024 to 2034
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
6.3. Revenue Opportunity Scenario- Likely/Conservative/Optimistic
7. Global Market Analysis 2019 to 2022 and Forecast 2024 to 2034, By Region
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ million) Analysis By Region, 2019 to 2022
7.3. Current and Future Market Size (US$ million)
7.4. Analysis and Forecast By Region, 2024 to 2034
7.4.1. North America
7.4.2. Latin America
7.4.3. East Asia
7.4.4. South Asia & Pacific
7.4.5. Western Europe
7.4.6. Eastern Europe
7.4.7. Middle East & Africa
7.5. Market Attractiveness Analysis By Region
8. Global Market Analysis 2019 to 2022 and Forecast 2024 to 2034, By Test Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ million Analysis By Test Type, 2019 to 2022
8.3. Current and Future Market Size (US$ million) Analysis and Forecast By Test Type, 2024 to 2034
8.3.1. NGS Based
8.3.2. PCR Based
8.4. Market Attractiveness Analysis By Test Type
9. Global Market Analysis 2019 to 2022 and Forecast 2024 to 2034, By Sample Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ million) By Sample Type, 2019 to 2022
9.3. Current and Future Market Size (US$ million) Analysis and Forecast By Sample Type, 2024 to 2034
9.3.1. Tissue
9.3.2. Plasma
9.4. Market Attractiveness Analysis By Sample Type
10. Global Market Analysis 2019 to 2022 and Forecast 2024 to 2034, By End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ million) By End User, 2019 to 2022
10.3. Current and Future Market Size (US$ million) Analysis and Forecast By End User, 2024 to 2034
10.3.1. Hospital Associated Labs
10.3.2. Independent Diagnostic Laboratories
10.3.3. Diagnostic Imaging Centers
10.3.4. Cancer Research Institutes
10.4. Market Attractiveness Analysis By End User
11. North America Market Analysis 2019 to 2022 and Forecast 2024 to 2034
11.1. Introduction
11.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2022
11.3. Current and Future Market Size (US$ million) & Forecast by Market Taxonomy, 2024 to 2034
11.3.1. By Country
11.3.1.1. United States
11.3.1.2. Canada
11.3.1.3. Mexico
11.3.2. By Test Type
11.3.3. By Sample Type
11.3.4. By End User
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Test Type
11.4.3. By Sample Type
11.4.4. By End User
11.5. Drivers and Restraints - Impact Analysis
11.6. Country Level Analysis & Forecast
11.6.1. United States Market Analysis
11.6.1.1. Introduction
11.6.1.2. Market Analysis and Forecast by Market Taxonomy
11.6.1.2.1. By Test Type
11.6.1.2.2. By Sample Type
11.6.1.2.3. By End User
11.6.2. Canada Market Analysis
11.6.2.1. Introduction
11.6.2.2. Market Analysis and Forecast by Market Taxonomy
11.6.2.2.1. By Test Type
11.6.2.2.2. By Sample Type
11.6.2.2.3. By End User
11.6.3. Mexico Market Analysis
11.6.3.1. Introduction
11.6.3.2. Market Analysis and Forecast by Market Taxonomy
11.6.3.2.1. By Test Type
11.6.3.2.2. By Sample Type
11.6.3.2.3. By End User
12. Latin America Market Analysis 2019 to 2022 and Forecast 2024 to 2034
12.1. Introduction
12.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2022
12.3. Current and Future Market Size (US$ million) & Forecast by Market Taxonomy, 2024 to 2034
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Chile
12.3.1.3. Rest of Latin America
12.3.2. By Test Type
12.3.3. By Sample Type
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Test Type
12.4.3. By Sample Type
12.4.4. By End User
12.5. Drivers and Restraints - Impact Analysis
12.6. Country Level Analysis & Forecast
12.6.1. Brazil Market Analysis
12.6.1.1. Introduction
12.6.1.2. Market Analysis and Forecast by Market Taxonomy
12.6.1.2.1. By Test Type
12.6.1.2.2. By Sample Type
12.6.1.2.3. By End User
12.6.2. Chile Market Analysis
12.6.2.1. Introduction
12.6.2.2. Market Analysis and Forecast by Market Taxonomy
12.6.2.2.1. By Test Type
12.6.2.2.2. By Sample Type
12.6.2.2.3. By End User
13. East Asia Market Analysis 2019 to 2022 and Forecast 2024 to 2034
13.1. Introduction
13.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2022
13.3. Current and Future Market Size (US$ million) & Forecast by Market Taxonomy, 2024 to 2034
13.3.1. By Country
13.3.1.1. China
13.3.1.2. Japan
13.3.1.3. South Korea
13.3.2. By Test Type
13.3.3. By Sample Type
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Test Type
13.4.3. By Sample Type
13.4.4. By End User
13.5. Drivers and Restraints - Impact Analysis
13.6. Country Level Analysis & Forecast
13.6.1. China Market Analysis
13.6.1.1. Introduction
13.6.1.2. Market Analysis and Forecast by Market Taxonomy
13.6.1.2.1. By Test Type
13.6.1.2.2. By Sample Type
13.6.1.2.3. By End User
13.6.2. Japan Market Analysis
13.6.2.1. Introduction
13.6.2.2. Market Analysis and Forecast by Market Taxonomy
13.6.2.2.1. By Test Type
13.6.2.2.2. By Sample Type
13.6.2.2.3. By End User
13.6.3. South Korea Market Analysis
13.6.3.1. Introduction
13.6.3.2. Market Analysis and Forecast by Market Taxonomy
13.6.3.2.1. By Test Type
13.6.3.2.2. By Sample Type
13.6.3.2.3. By End User
14. South Asia & Pacific Market Analysis 2019 to 2022 and Forecast 2024 to 2034
14.1. Introduction
14.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2022
14.3. Current and Future Market Size (US$ million) & Forecast by Market Taxonomy, 2024 to 2034
14.3.1. By Country
14.3.1.1. India
14.3.1.2. ASEAN Countries
14.3.1.3. Australia & New Zealand
14.3.1.4. Rest of South Asia and Pacific
14.3.2. By Test Type
14.3.3. By Sample Type
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Test Type
14.4.3. By Sample Type
14.4.4. By End User
14.5. Drivers and Restraints - Impact Analysis
14.6. Country Level Analysis & Forecast
14.6.1. India Market Analysis
14.6.1.1. Introduction
14.6.1.2. Market Analysis and Forecast by Market Taxonomy
14.6.1.2.1. By Test Type
14.6.1.2.2. By Sample Type
14.6.1.2.3. By End User
14.6.2. ASEAN Countries Market Analysis
14.6.2.1. Introduction
14.6.2.2. Market Analysis and Forecast by Market Taxonomy
14.6.2.2.1. By Test Type
14.6.2.2.2. By Sample Type
14.6.2.2.3. By End User
14.6.3. Australia & New Zealand Market Analysis
14.6.3.1. Introduction
14.6.3.2. Market Analysis and Forecast by Market Taxonomy
14.6.3.2.1. By Test Type
14.6.3.2.2. By Sample Type
14.6.3.2.3. By End User
15. Western Europe Market 2019-2022 and Forecast 2024 to 2034
15.1. Introduction
15.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2022
15.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. United Kingdom
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Nordic Countries
15.3.1.8. Rest of Western Europe
15.3.2. By Test Type
15.3.3. By Sample Type
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Test Type
15.4.3. By Sample Type
15.4.4. By End User
15.5. Drivers and Restraints - Impact Analysis
15.6. Country Level Analysis & Forecast
15.6.1. Germany Market Analysis
15.6.1.1. Introduction
15.6.1.2. Market Analysis and Forecast by Market Taxonomy
15.6.1.2.1. By Test Type
15.6.1.2.2. By Sample Type
15.6.1.2.3. By End User
15.6.2. France Market Analysis
15.6.2.1. Introduction
15.6.2.2. Market Analysis and Forecast by Market Taxonomy
15.6.2.2.1. By Test Type
15.6.2.2.2. By Sample Type
15.6.2.2.3. By End User
15.6.3. Spain Market Analysis
15.6.3.1. Introduction
15.6.3.2. Market Analysis and Forecast by Market Taxonomy
15.6.3.2.1. By Test Type
15.6.3.2.2. By Sample Type
15.6.3.2.3. By End User
15.6.4. Italy Market Analysis
15.6.4.1. Introduction
15.6.4.2. Market Analysis and Forecast by Market Taxonomy
15.6.4.2.1. By Test Type
15.6.4.2.2. By Sample Type
15.6.4.2.3. By End User
15.6.5. BENELUX Market Analysis
15.6.5.1. Introduction
15.6.5.2. Market Analysis and Forecast by Market Taxonomy
15.6.5.2.1. By Test Type
15.6.5.2.2. By Sample Type
15.6.5.2.3. By End User
15.6.6. Nordic Countries Market Analysis
15.6.6.1. Introduction
15.6.6.2. Market Analysis and Forecast by Market Taxonomy
15.6.6.2.1. By Test Type
15.6.6.2.2. By Sample Type
15.6.6.2.3. By End User
15.6.7. United Kingdom Market Analysis
15.6.7.1. Introduction
15.6.7.2. Market Analysis and Forecast by Market Taxonomy
15.6.7.2.1. By Test Type
15.6.7.2.2. By Sample Type
15.6.7.2.3. By End User
16. Eastern Europe Market Analysis 2019 to 2022 and Forecast 2024 to 2034
16.1. Introduction
16.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2022
16.3. Current and Future Market Size (US$ million) & Forecast by Market Taxonomy, 2024 to 2034
16.3.1. By Country
16.3.1.1. Russia
16.3.1.2. Hungary
16.3.1.3. Poland
16.3.1.4. Rest of Eastern Europe
16.3.2. By Test Type
16.3.3. By Sample Type
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Test Type
16.4.3. By Sample Type
16.4.4. By End User
16.5. Drivers and Restraints - Impact Analysis
16.6. Country Level Analysis & Forecast
16.6.1. Russia Market Analysis
16.6.1.1. Introduction
16.6.1.2. Market Analysis and Forecast by Market Taxonomy
16.6.1.2.1. By Test Type
16.6.1.2.2. By Sample Type
16.6.1.2.3. By End User
16.6.2. Hungary Market Analysis
16.6.2.1. Introduction
16.6.2.2. Market Analysis and Forecast by Market Taxonomy
16.6.2.2.1. By Test Type
16.6.2.2.2. By Sample Type
16.6.2.2.3. By End User
16.6.3. Poland Market Analysis
16.6.3.1. Introduction
16.6.3.2. Market Analysis and Forecast by Market Taxonomy
16.6.3.2.1. By Test Type
16.6.3.2.2. By Sample Type
16.6.3.2.3. By End User
17. Middle East & Africa Market Analysis 2019 to 2022 and Forecast 2024 to 2034
17.1. Introduction
17.2. Key Players Analyzed
17.3. Historical Market Size (US$ million) by Market Taxonomy, 2019 to 2022
17.4. Current and Future Market Size (US$ million) and Forecast by Market Taxonomy, 2024 to 2034
17.4.1. By Country
17.4.1.1. Saudi Arabia
17.4.1.2. Türkiye
17.4.1.3. South Africa
17.4.1.4. Other African Union
17.4.1.5. Rest of Middle East & Africa
17.4.2. By Test Type
17.4.3. By Sample Type
17.4.4. By End User
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Test Type
17.5.3. By Sample Type
17.5.4. By End User
17.6. Drivers and Restraints - Impact Analysis
17.7. Country Level Analysis & Forecast
17.7.1. Saudi Arabia Market Analysis
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast by Market Taxonomy
17.7.1.2.1. By Test Type
17.7.1.2.2. By Sample Type
17.7.1.2.3. By End User
17.7.2. Türkiye Market Analysis
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast by Market Taxonomy
17.7.2.2.1. By Test Type
17.7.2.2.2. By Sample Type
17.7.2.2.3. By End User
17.7.3. South Africa Market Analysis
17.7.3.1. Introduction
17.7.3.2. Market Analysis and Forecast by Market Taxonomy
17.7.3.2.1. By Test Type
17.7.3.2.2. By Sample Type
17.7.3.2.3. By End User
17.7.4. Other African Union Market Analysis
17.7.4.1. Introduction
17.7.4.2. Market Analysis and Forecast by Market Taxonomy
17.7.4.2.1. By Test Type
17.7.4.2.2. By Sample Type
17.7.4.2.3. By End User
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Share Analysis of Top Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Branding & Promotional Strategies by Key Players
19.4. Competition Deep Dive
19.4.1. APIS Assay Technologies
19.4.1.1. Overview
19.4.1.2. Product Portfolio
19.4.1.3. Key Financials
19.4.1.4. SWOT Analysis
19.4.1.5. Key Developments
19.4.1.6. Sales Footprint
19.4.1.7. Strategy Overview
19.4.1.7.1. Marketing Strategy
19.4.1.7.2. Product Strategy
19.4.1.7.3. Channel Strategy
19.4.2. Illumina, Inc.
19.4.3. GENCURIX
19.4.4. RainSure Scientific
19.4.5. NeoGenomics Laboratories
19.4.6. Sysmex Corporation
19.4.7. ASURAGEN, INC.
19.4.8. Guardant Health
20. Assumptions and Acronyms Used
21. Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings